nik-macmillan-280300.jpg

investors

 
 

STOCK INFORMATION

BlissCo is currently trading on the following stock exchanges:

Canadian Stock Exchange (CSE) as BlissCo Cannabis Corp. (BLIS)

Frankfurt Stock Exchange (FRA) as GQ4B:GR

 

BlissCo Hires Experienced Clinic Leader to Drive Revenue with Patient Care and Call Center Programs

  • Not for distribution in the U.S. or to U.S. newswire services.

Vancouver, British Columbia – August 9, 2018 – BlissCo Cannabis Corp. (FRA: GQ4B) (CSE: BLIS), (“BlissCo”) or the (“Company”) is pleased to announce that the company has added Shannon Khan to its team to serve as Patient Care and Call Center Lead.

Ms. Khan is a Licensed Practical Nurse who has served as a leader in the Dr. Bernstein Diet and Health Clinics. She spent over six years as the clinic and regional manager at multiple Dr. Bernstein clinics in Calgary and Vancouver where she led teams of up to 20.

“We are pleased to welcome Ms. Khan to our team. High-quality patient care is a top priority for BlissCo and our primary focus in Canada is the medical cannabis market. Her experience with a national clinic such as Dr. Bernstein’s Diet and Health Clinics will be a strong asset to our team as we focus on patient acquisition and retention,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp.

BlissCo’s telemedicine app is planned to launch in October, with the service being delivered in partnership with leading e-commerce provider, Namaste Technologies (TSXV: N).

 

About BlissCo Cannabis Corp.

BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B) is an ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.  

BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo's future patients and customers.

Learn more: BlissCo.com

 

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

 

For further information please contact:

Ariel Jack Lewinski, Business Development & Investor Relations 

 1-604-377-7533

ariel.lewinski@blissco.com

 

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

See All Investor Updates

OUR COMPANY

As Canada is primed as a global leader and first mover in the cannabis industry, BlissCo is uniquely poised in the rapidly growing multi-billion dollar market and in various international markets as cannabis regulations progress.

BlissCo, founded in 2013, is a Canadian vertically integrated cultivation, extraction and distribution focused cannabis brand that earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) license to cultivate from Health Canada on March 29, 2018.

BlissCo's state-of-the-art production facility, located in Metro Vancouver, is purposefully designed as a hub for research, cultivation, processing, extraction, packaging and distribution.

Now with the ACMPR license to cultivate, BlissCo will commence its operation to harvest premium cannabis within its' urban facility in Metro Vancouver.  BlissCo also has a multi-year supply agreement in place with a Canadian Licensed Producer of characteristically sun-grown premium medicinal cannabis to purchase supply in large volumes (news release). This premium bulk cannabis will be brought to our secure and pristine facility in British Columbia for processing and then be packaged for sale and distribution to our growing patient list when BlissCo has appropriately received its license for sale. 

BlissCo was founded with the assistance of a team of advisors, including medical and naturopathic doctors, has intentionally engaged with the medical community to understand how to contribute to improved patient health with medicinal cannabis products. A large part of our strategy for growth centres on how to securely integrate and collaborate with the healthcare system.

The BlissCo team has deep domain expertise in the critical category success areas:

  • Multi-province controlled substance distribution (BC and Alberta)
  • Cultivation and product safety, consistency and security
  • Indoor cultivation, controlled environments ensuring high standards &  consistent products.
  • Quality assurance, product safety, 3rd Party GMP Audits & Certifications.


Milestones

2018

February

Strategic partnership with the Supreme Cannabis Company

Trading on Canadian Securities Exchange (CSE:BLIS)

March
ACMPR License to Produce earned

May

Cannabis plant starting material to arrive at BlissCo's facility and growing commences. 

ACMPR Cannabis Oil Extraction License application submitted

June

Sign agreement to export 720 kilograms of medical cannabis to Germany

July

ACMPR License to Sell application submitted

Sign supply agreement with GreenSeal Cannabis

Sign e-commerce and technology service agreement with Namaste Technologies (TSXV: N) 

2017

February
Confirmation of Readiness for Inspection received from Health Canada

May
Confirmation of Readiness for License from Health Canada

August
Close on purchasing facility for $2.4m

September
Earn Building Permit from Township of Langley
Commence Construction

2014

July
ACMPR Licensed Submitted